Connect with People

The world is a book. Those who do not connect with others miss many pages.
Invite

Browse Members

  • Age
  •  
  •  
    •  
  • perryf reeman

  • Krystal Charles

  • fitness sdsd

  • marushi sujain

  • the technovate

  • vonne bace

  • hbomax com/tvsignin

  • martin amelia

  • James Corner

  • Kevin Doe Nearly 300 non-invasive diagnostic tests, Claims Roots Analysis Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease. To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments: § Type of Tumor Marker ctDNA cfDNA CTCs Exosomes Others § Application Diagnosis / Early Diagnosis Patient Monitoring Recurrence Monitoring § Target Cancer Indication Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Bladder Cancer Melanoma Gastric Cancer Pancreatic Cancer Ovarian Cancer Others § End Users Hospitals Research Institutes Others § Key Geographical Regions North America Europe Asia-Pacific Rest of the World The “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”report features the following companies, which we identified to be key players in this domain: § Amoy Diagnostics § DiaCarta § HaploX Biotechnology § NeoGenomics § QIAGEN § Swift Biosciences § Sysmex Inostics § Thermo Fisher Scientific To request for sample report - https://www.rootsanalysis.com/reports/279/request-sample.html Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Non-Invasive Cancer Screening and Diagnosis 5. Market Landscape 6. Company Profiles 7. Partnerships and Collaborations 8. Funding and Investment Analysis 9. Liquid Biopsy: Initiatives of Big Pharma Players 10. Key Acquisition Targets 11. Other Non-Invasive Cancer Diagnostics 12. Market Sizing and Opportunity Analysis 13. Survey Insights 14. Conclusion 15. Executive Insights 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Other Recent Offerings: 1. Antibody Drug Conjugates Market (5th Edition), 2019-2030 2. Gene Therapy Market (3rd Edition), 2019 - 2030 3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030 Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    August 23, 2021